Karyopharm Therapeutics Inc (NASDAQ:KPTI) At $0.91: Does It Look Expensive?
In recent trading session, Karyopharm Therapeutics Inc (NASDAQ:KPTI) saw 0.42 million shares changing hands at last check today with its beta currently measuring 0.07. Company’s